Revenue
$9.05B
Fiscal year ended 2026-04-30Operating income
$360.20M
Fiscal year ended 2026-04-30Free cash flow
$1.16B
Fiscal year ended 2026-04-30J M SMUCKER Co (SJM) reported revenue of $9.05B and net income of -$138.70M for the fiscal year ended 2026-04-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from J M SMUCKER Co’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.05B | $8.73B | $8.18B | $8.53B | $8.00B | $8.00B | $7.80B | $7.84B | $7.36B | $7.39B |
| Cost of revenue | $6.02B | $5.34B | $5.06B | $5.73B | $5.30B | $4.86B | $4.80B | $4.92B | $4.52B | $4.56B |
| Gross profit | $3.03B | $3.38B | $3.12B | $2.80B | $2.70B | $3.14B | $3.00B | $2.92B | $2.84B | $2.84B |
| Operating income | $360.20M | -$673.90M | $1.31B | $157.50M | $1.02B | $1.39B | $1.22B | $928.60M | $1.04B | $1.04B |
| Net income | -$138.70M | -$1.23B | $744.00M | -$91.30M | $631.70M | $876.30M | $779.50M | $514.40M | $1.34B | $592.30M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $58.10M |
| Weighted-average diluted shares | Unavailable | Unavailable | Unavailable | Unavailable | shares 108.40M | shares 112.00M | shares 113.40M | shares 113.10M | shares 113.00M | shares 115.60M |
| Pretax income | -$62.40M | -$1.05B | $996.40M | -$9.20M | $843.80M | $1.17B | $1.03B | $701.60M | $861.00M | $878.40M |
| Income tax expense | $76.30M | $184.00M | $252.40M | $82.10M | $212.10M | $295.60M | $247.20M | $187.20M | -$477.60M | $286.10M |
| Diluted EPS | $-1.30 | $-11.57 | $7.13 | $-0.86 | $5.83 | $7.79 | $6.84 | $4.52 | $11.78 | $5.10 |
| Selling, general & administrative | $1.50B | $1.53B | $1.45B | $1.46B | $1.36B | $1.52B | $1.47B | $1.51B | $1.36B | $1.38B |
| General & administrative | $328.10M | $322.50M | $305.50M | $313.10M | $258.70M | $323.90M | $298.10M | $292.00M | $287.50M | $313.80M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $101.30M | $192.60M | $166.80M |
| Total assets | $16.22B | $17.56B | $20.27B | $14.99B | $16.06B | $16.28B | $16.97B | $16.71B | $15.30B | $15.64B |
| Current assets | $1.97B | $2.15B | $1.97B | $2.86B | $2.01B | $1.94B | $1.97B | $1.63B | $1.56B | $1.64B |
| Total liabilities | $10.68B | $11.48B | $12.58B | $7.70B | $7.91B | $8.16B | $8.78B | $8.74B | $7.41B | $8.79B |
| Current liabilities | $2.54B | $2.65B | $3.76B | $1.99B | $1.95B | $2.87B | $1.59B | $2.34B | $1.03B | $1.83B |
| Total equity incl. NCI | $5.54B | $6.08B | $7.69B | $7.29B | $8.14B | $8.12B | $8.19B | $7.97B | $7.89B | $6.85B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.13B | $1.21B | $1.04B | $1.01B | $1.09B | $959.90M | $895.30M | $910.30M | $854.40M | $905.70M |
| Accounts receivable | $656.30M | $619.00M | $736.50M | $597.60M | $524.70M | $533.70M | $551.40M | $503.80M | $385.60M | $438.70M |
| Goodwill | $5.20B | $5.71B | $7.65B | $5.22B | $6.02B | $6.02B | $6.30B | $6.31B | $5.94B | $6.08B |
| Long-term debt | $6.39B | $7.04B | $6.77B | $4.31B | $4.31B | $3.52B | $5.37B | $4.69B | $4.69B | $4.45B |
| Accounts payable | $1.18B | $1.29B | $1.34B | $1.39B | $1.19B | $1.03B | $782.00M | $591.00M | $512.10M | $477.20M |
Cash flow
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.47B | $1.21B | $1.23B | $1.19B | $1.14B | $1.56B | $1.25B | $1.14B | $1.22B | Unavailable |
| Capital expenditures | $317.40M | $393.80M | $586.50M | $477.40M | $417.50M | $306.70M | $269.30M | $359.80M | $321.90M | $192.40M |
| Investing cash flow | -$258.80M | -$100.30M | -$3.96B | $256.20M | -$355.50M | $311.10M | -$271.50M | -$1.92B | -$277.60M | Unavailable |
| Financing cash flow | -$1.23B | -$1.10B | $2.14B | -$964.60M | -$944.50M | -$1.94B | -$688.70M | $699.00M | -$922.00M | Unavailable |
| Net change in cash | -$11.30M | $7.90M | -$593.80M | $485.90M | -$164.40M | -$56.80M | $289.80M | -$91.30M | $25.80M | $57.00M |
| Stock-based compensation | $23.60M | $29.90M | $23.90M | $25.60M | $22.30M | $28.70M | $26.80M | $20.70M | $15.40M | $22.00M |
| Common dividends paid | $464.70M | $455.40M | $437.50M | $430.20M | $418.10M | $403.20M | $396.80M | $377.90M | $350.30M | $339.30M |
| Common share repurchases | $5.60M | $3.30M | $372.80M | $367.50M | $270.40M | $678.40M | $4.20M | $5.40M | $7.00M | $437.60M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.16B | $816.60M | $642.90M | $717.00M | $718.80M | $1.26B | $985.50M | $781.40M | $896.10M | Unavailable |
| Gross margin | 33.5% | 38.8% | 38.1% | 32.8% | 33.8% | 39.2% | 38.5% | 37.2% | 38.5% | 38.4% |
| Operating margin | 4.0% | -7.7% | 16.0% | 1.8% | 12.8% | 17.3% | 15.7% | 11.8% | 14.2% | 14.1% |
| FCF margin | 12.8% | 9.4% | 7.9% | 8.4% | 9.0% | 15.7% | 12.6% | 10.0% | 12.2% | Unavailable |
| SBC / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.3% | 0.3% | 0.2% | 0.3% |
| Current ratio | 0.78x | 0.81x | 0.52x | 1.44x | 1.03x | 0.68x | 1.24x | 0.69x | 1.50x | 0.90x |
| Revenue YoY growth | 3.7% | 6.7% | -4.1% | 6.6% | -0.0% | 2.6% | -0.5% | 6.5% | -0.5% | Unavailable |
| Net margin | -1.5% | -14.1% | 9.1% | -1.1% | 7.9% | 11.0% | 10.0% | 6.6% | 18.2% | 8.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 3.5% | 4.5% | 7.2% | 5.6% | 5.2% | 3.8% | 3.5% | 4.6% | 4.4% | 2.6% |
| Long-term debt / equity | 1.15x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | 25.3% | Unavailable | 25.1% | 25.2% | 24.1% | 26.7% | -55.5% | 32.6% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SJM in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-26View SEC filing
10-K · Filed 2026-06-09View SEC filing
10-Q · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-27View SEC filing
10-K · Filed 2025-06-18View SEC filing
Companies in the same industry
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.